Os20 - Prioritization of vaccines – approaches to maximizing impact - Alasdair King

•

0 likes•293 views

Prioritization of vaccines is necessary due to resource constraints, and can be an effective way to maximize impact. Approaches to prioritization include focusing vaccination efforts by risk area, circulating strain, time period, or vaccine type. Effective prioritization requires thorough planning through disease surveillance, forecasting needs, setting clear objectives, and stakeholder engagement.

Health & Medicine

1EuFMD | Open Session special edition | #OS20se
Prioritisation of Vaccines – Approaches to
Maximising Impact
Dr Alasdair King
International Veterinary Health
Merck Animal Health, USA

2
The Need For Prioritization
• Resource constraints lead to compromise
• But work shows prioritization is effective
• Need to consider how to maximize impact?

3
Prioritization
PLANNING
• Surveillance – where is the
disease
• Forecasting – what is the need
• Objective – eradicate, control,
remain free
• Involvement – engage
stakeholders
APPROACHES
• By risk area*
• By circulating strain*
• By time
• By vaccine

4
Summary
• There are limited resources
• Prioritization is cost effective
• What is your objective
• Consider various solutions
• Communicate with all stakeholders

Vaccine banks provide a unique solution to address emergency vaccine needs by maintaining a stockpile of quality vaccines. While there is constant competition for regular and surge vaccine demands, banks ensure there is idle manufacturing capacity ready to serve increases in demand. Banks have been an acknowledged tool for disease-free countries, but can also help minimize vaccine shortages in endemic countries. They serve as a buffer stock to respond to sudden surges, insure against exotic strains, and trigger vaccination campaigns. Regional banks funded by international organizations provide a sustainable model and help transfer ownership to countries.

OS20 - California FMD vaccination planning - L. Quiroz/ P. Hullinger

EuFMD

California has developed a vaccination plan as part of its FMD response due to challenges with stamping out, including dense dairy farms and limited rendering capacity. The plan requires advanced preparation, such as establishing protocols for receiving, storing, and administering vaccine. Officials will work with industry groups and veterinarians to identify bottlenecks and socialize the concept of vaccination. The objective is to be prepared to effectively use vaccination if an FMD outbreak occurs in California.

OS20 - Effective risk communication for animal disease emergencies - Lisa Bo...

EuFMD

Professor Lisa Boden discusses effective risk communication for animal disease emergencies. She notes that communicating known risks and knowledge gaps to relevant stakeholders and society is a professional and moral imperative. The presentation explores risk communication aims and effective strategies, considering barriers and opportunities. It concludes that timely, audience-appropriate communication leads to better risk management and ensures up-to-date knowledge informs decision making.

OS20 - Risk factors associated with FMD endemicity in eastern Rwanda. - Jea...

EuFMD

The document summarizes a study investigating risk factors for foot-and-mouth disease (FMD) outbreaks in eastern Rwanda. The study found that 40.15% of farmers did not vaccinate calves under 12 months of age, which was associated with increased FMD outbreaks. Having sheep and goats on the same farm was also linked to higher chances of outbreaks. Surprisingly, farms further from the park fence experienced more FMD than those adjacent, possibly due to less impact from transboundary animal movements after the park was fenced in 2013. The study recommends expanding vaccination programs to target both older and younger cattle.

Vaccine security meeting - development amnd perspectives - D.John

EuFMD

Mahoney Panama Dpb July 2009 V2

gambelguy

The document discusses five elements that are important for the introduction and implementation of dengue vaccines: establishing disease burden data and cost-effectiveness analyses, conducting vaccine introduction trials and effectiveness evaluations, developing international recommendations for vaccine use, ensuring adequate and competitive vaccine supply, and creating funding mechanisms for procurement. It also outlines the current status and challenges for each of these elements and proposes next steps like developing country-specific plans through regional seminars.

Mahoney 3rd Wvc Dengue Regulation V2

gambelguy

1) Development of dengue vaccines requires addressing regulatory issues like evaluating efficacy against the four virus serotypes and safety regarding antibody-dependent enhancement. 2) Clinical trials are most likely to occur first in developing countries with dengue, where discussions among regulators can define the approval pathway with WHO's guidance. 3) It is important to standardize diagnostic tests and identify a correlate of protection to help evaluate vaccines.

Anders Wallensten: SHARP WP5 Brief Introduction – Strengthening IHR Core Capa...

THL

Greg Evans has extensive qualifications and experience in food safety management systems. He has led the implementation of food safety plans in public hospitals in Western Australia and assisted other health regions. Evans also developed a unique web-based food safety management and audit system in 2006-2007. He has lectured at several universities and delivered many presentations industrywide on topics related to food safety and foodborne illness outbreak investigations.

OS20 - Factors influencing decision-making for foot-and-mouth disease contro...

EuFMD

The document summarizes factors that influence decision-making for foot-and-mouth disease control in Kenya. Key informant interviews revealed inconsistent prioritization of animal disease control, separate lines of strategic guidance and accountability/budgeting, and private veterinarians involved in disease reporting and vaccination outside of official guidance and accountability. There are opportunities to provide more relevant disease data to farmers and veterinarians and ensure information flows in both directions. Strengthening FMD control could include reinforcing programmatic strengths through a participatory national strategy, integrated public-private partnerships, and accountability mechanisms that promote two-way communication.

Inventory among DEMETER Stakeholders on EMERGING RISKS Systems

AGINFRA

OS16 - 1.4.a Encouraging the Use of Vaccination-To-Live as a Control Strate...

EuFMD

Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)

THL

Future Health Challenges: Developing Global Norms for Data and Results Sharin...

ExternalEvents

OS20 - Foot-and-Mouth Disease risk mapping in Georgia - Tengiz Chaligava

EuFMD

This document summarizes a risk mapping project in Georgia that aimed to improve risk assessment of foot-and-mouth disease introduction and spread. Several risk factors were identified including live animal markets, migration, export, and import. Districts across Georgia were involved based on these factors. The study found higher animal mobility and risk in Eastern Georgia compared to other areas, confirming the focus of control efforts there. Future risk maps of neighboring countries will allow for better disease risk predictions and targeted control measures.

Data Needs for Epidemic Control

LINKAGES

Dr. Lauri Hicks - Out-Patient Antibiotic Resistance (AMR) Issues

John Blue

Out-Patient Antibiotic Resistance (AMR) Issues - Dr. Lauri Hicks, Commander, U.S. Public Health Service, Medical Epidemiologist, Respiratory Diseases Branch; Medical Director, Get smart: Know When Antibiotic Work Program; Centers for Disease Control and Prevention (CDC), from the 2015 NIAA Antibiotic Symposium - Stewardship: From Metrics to Management, November 3-5, 2015, Atlanta, Georgia, USA. More presentations at http://swinecast.com/2015-niaa-symposium-antibiotics-stewardship-from-metrics-to-management

Cdc get smart week resident presentation 2014

katejohnpunag

This document discusses antibiotic overuse and resistance. It notes that overuse of antibiotics can lead to adverse drug events, antibiotic resistance, and Clostridium difficile infections. It summarizes the 2013 CDC Threat Report on antibiotic resistance and lists several "superbugs" as major threats. The document advocates for antibiotic stewardship programs and lists seven ways healthcare providers can improve antibiotic prescribing practices to help address the growing crisis of antibiotic resistance.

Workshop presentation

Soumya Ranjan Parida

The document outlines the key components of the WHO Stop TB Strategy released in 2006, including its vision of a TB-free world and objectives of achieving universal access to high-quality TB care. It discusses ensuring quality-assured diagnosis and treatment decentralization with over 600,000 DOT providers. It also notes the importance of coordination mechanisms, engaging all care providers through public-private mix, empowering patients and communities through advocacy, and enabling research.

Implementing A Network Of Virology And Entomology Laboratories For A OH Appro...

Global Risk Forum GRFDavos

This document summarizes the MediLabSecure project, which aims to create a network of virology and entomology laboratories in the Mediterranean and Black Sea regions to improve surveillance of vector-borne and respiratory viruses using a One Health approach. The project will enhance preparedness for health emergencies by strengthening laboratory capacity for diseases like West Nile virus, Crimean-Congo hemorrhagic fever, Rift Valley fever, coronaviruses, and their vectors. It will provide training, promote best practices, and facilitate collaboration between 55 laboratories across 19 countries from 2014-2017 with funding from the European Union.

Mika Aaltola, Ulkopoliittinen instituutti - Pandemic governance scenarios in ...

Maa- ja metsätalousministeriö

The document discusses key questions around global health security, including how to prevent the spread of antimicrobial resistant organisms and zoonotic diseases through strengthened international frameworks and biosafety systems. It also addresses how to improve detection of diseases through global surveillance networks and reporting standards as well as how to develop an interconnected global network for multi-sector responses to biological incidents and access to countermeasures. Infectious diseases ignore national borders so proactive prevention and combating of diseases is necessary nationally and internationally through comprehensive cooperation.

Mirjam Maeusezahl: Joint External Evaluations (JEE) – Country experiences: Sw...

THL

The document discusses Switzerland's participation in the Joint External Evaluation (JEE) conducted by the World Health Organization. It provides details on Switzerland's implementation of the International Health Regulations, the timeline and milestones of the JEE process, and lessons learned. Key results showed room for improvement in antimicrobial resistance detection and response as well as strengthening surveillance systems for zoonotic diseases. Switzerland adapted the WHO National Action Plan template to monitor progress in addressing JEE recommendations internally.

Global Health Security Agenda GHSA

Global Health Security Agenda

Phytothreats: DEFRA

Forest Research

This document summarizes Richard McIntosh's role as Assistant Chief Plant Officer at Defra and discusses the UK Plant Health Risk Group process. It also touches on some challenges and desired outcomes of a project focused on phytophthoras. Specifically: 1) McIntosh oversees Defra's Plant Health Risk and Horizon Scanning Team and represents the UK in EU plant health meetings. 2) The UK Plant Health Risk Group identifies pest threats, assesses risks, and proposes responses which are confirmed by the Chief Plant Health Officer and potentially escalated to Ministers. 3) The project on phytophthoras faces challenges in prioritizing the vast number of species, dealing with unknown risks and

Developing a national strategy to bring pathogen genomics into practice

ExternalEvents

One Health Approach For CCHF Surveillance In Kazakhstan Andrey UKHAROV

Global Risk Forum GRFDavos

This document discusses using an electronic integrated disease surveillance system (EIDSS) to forecast Crimean-Congo hemorrhagic fever (CCHF) outbreak risks in Kazakhstan. EIDSS strengthened disease monitoring within a One Health approach. Analysis of human, vector, and laboratory data from 2007-2011 predicted CCHF risk maps for 2013, which accurately forecasted outbreak risks for 88.9% of historically affected districts. The results demonstrate EIDSS is a reliable tool for CCHF prognosis and risk management that can help decision-making and expand statistical surveillance within a systematic One Health framework.

Strengthening data sharing for public health: ethical, legal and political is...

ExternalEvents

VADEMOS VAccine Demand Estimation Model for FMD.pdf

EuFMD

VADEMOS is a decision support tool created by the European Commission for the Control of Foot-and-Mouth Disease to estimate current and future vaccine demand for foot-and-mouth disease at national and regional levels. It uses factors like livestock population forecasts, disease control policies, vaccination schedules, and outbreak forecasts with data from sources like WOAH and FAOSTAT. The model provides outputs on expected vaccine doses needed by geography, type of vaccination, species, and year over a 10-year period. While validation is needed, the tool generally predicts vaccine needs within calculated ranges, though estimates are sometimes too high. Future work will refine inputs, add additional geographical specificity, and expand the model to other diseases.

Vaccine delivery and demand workshop

EuFMD

This document provides an introduction to vaccine value chains and outlines EuFMD/FAO initiatives to strengthen vaccine security. It discusses how vaccine value chains involve both private and public actors across product development, production, allocation, distribution and use. Cross-cutting factors like epidemiology, logistics and stakeholder engagement are also important. EuFMD is supporting activities to improve vaccine access and availability through a multistakeholder platform, prequalification of vaccines, vaccine demand modeling, and strengthening vaccine delivery and demand. Analyzing vaccine value chains can help understand costs and demand to support effective vaccination programs.

What's hot

Pedro Alonso-Enfermedades transmitidas por vectores

Fundación Ramón Areces

G Evans Director F S Management Systems

Greg Evans

OS20 - Factors influencing decision-making for foot-and-mouth disease contro...

EuFMD

Inventory among DEMETER Stakeholders on EMERGING RISKS Systems

AGINFRA

OS16 - 1.4.a Encouraging the Use of Vaccination-To-Live as a Control Strate...

EuFMD

Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)

THL

Future Health Challenges: Developing Global Norms for Data and Results Sharin...

ExternalEvents

OS20 - Foot-and-Mouth Disease risk mapping in Georgia - Tengiz Chaligava

EuFMD

Data Needs for Epidemic Control

LINKAGES

Dr. Lauri Hicks - Out-Patient Antibiotic Resistance (AMR) Issues

John Blue

Cdc get smart week resident presentation 2014

katejohnpunag

Workshop presentation

Soumya Ranjan Parida

Implementing A Network Of Virology And Entomology Laboratories For A OH Appro...

Global Risk Forum GRFDavos

Mika Aaltola, Ulkopoliittinen instituutti - Pandemic governance scenarios in ...

Maa- ja metsätalousministeriö

Mirjam Maeusezahl: Joint External Evaluations (JEE) – Country experiences: Sw...

THL

Global Health Security Agenda GHSA

Global Health Security Agenda

Phytothreats: DEFRA

Forest Research

Developing a national strategy to bring pathogen genomics into practice

ExternalEvents

One Health Approach For CCHF Surveillance In Kazakhstan Andrey UKHAROV

Global Risk Forum GRFDavos

Strengthening data sharing for public health: ethical, legal and political is...

ExternalEvents

What's hot (20)

Pedro Alonso-Enfermedades transmitidas por vectores

G Evans Director F S Management Systems

OS20 - Factors influencing decision-making for foot-and-mouth disease contro...

Inventory among DEMETER Stakeholders on EMERGING RISKS Systems

OS16 - 1.4.a Encouraging the Use of Vaccination-To-Live as a Control Strate...

Daniela Jacob: Laboratory Preparedness and Responsiveness (SHARP JA WP7)

Future Health Challenges: Developing Global Norms for Data and Results Sharin...

OS20 - Foot-and-Mouth Disease risk mapping in Georgia - Tengiz Chaligava

Data Needs for Epidemic Control

Dr. Lauri Hicks - Out-Patient Antibiotic Resistance (AMR) Issues

Cdc get smart week resident presentation 2014

Workshop presentation

Implementing A Network Of Virology And Entomology Laboratories For A OH Appro...

Mika Aaltola, Ulkopoliittinen instituutti - Pandemic governance scenarios in ...

Mirjam Maeusezahl: Joint External Evaluations (JEE) – Country experiences: Sw...

Global Health Security Agenda GHSA

Phytothreats: DEFRA

Developing a national strategy to bring pathogen genomics into practice

One Health Approach For CCHF Surveillance In Kazakhstan Andrey UKHAROV

Strengthening data sharing for public health: ethical, legal and political is...

More from EuFMD

VADEMOS VAccine Demand Estimation Model for FMD.pdf

EuFMD

Vaccine delivery and demand workshop

EuFMD

Emergency vaccination workshop presentations 30 May 2023.pdf

EuFMD

This document summarizes a presentation on alternative post-vaccination surveillance methods that could be used to demonstrate the absence of foot-and-mouth disease (FMD) virus transmission in vaccinated and unvaccinated livestock populations. It proposes replacing serological testing with bulk milk testing for dairy farms, saliva testing using rope tethers for piggeries, and saliva swab testing for sheep farms. These alternative methods utilize real-time reverse transcription polymerase chain reaction to detect FMD viral RNA from oral fluid samples, which research has shown can identify infected animals. The presentation discussed how these new testing technologies may allow countries to gain freedom from FMD status sooner after an outbreak by providing more effective post-vaccination surveillance.

LSD symposium - N. Galon - Thinking out of the pox lessons and thoughts on LS...

EuFMD

LSD symposium - C. E. Lamien - Molecular epidemiological investigation of LSD...

EuFMD

LSD symposium - I. Gluecks - Cattle farming in Kenya, Africa livestock health...

EuFMD

LSD symposium - G. Pezzoni - Development of a pen-side test for the detection...

EuFMD

LSD symposium - A. Haegeman - LSDV transmission by stomoxys stable flies less...

EuFMD

LSD symposium - W. Philips - Evaluation of the efficacy of live attenuated he...

EuFMD

LSD symposium - A. Sprygin - Subclinical infection its role in transmission a...

EuFMD

The document discusses subclinical infection and its role in the transmission and epidemiology of Lumpy Skin Disease Virus (LSDV). It presents the body temperatures of experimental animals infected with LSDV over time. One animal showed clinical signs of LSDV while another showed viremia or presence of the virus in the blood without displaying clinical signs, representing a subclinical infection. The conclusion is that subclinical infection from vaccine-like recombinant LSDV can play a role in transmission of the virus.

LSD symposium - Z. Fatima- Investigation of suspected outbreaks of lumpy skin...

EuFMD

LSD symposium - L. Pite - Combating lumpy skin disease in Albania

EuFMD

1) The first case of Lumpy Skin Disease (LSD) in Albania was identified in June 2016. From 2016-2017, over 3,500 outbreaks were reported across Albania with morbidity of 42% and mortality of 12%. 2) Surveillance efforts included laboratory testing of over 2,000 samples confirming 881 positive cases. Risk factors for spread included proximity to infected farms (under 5km), livestock movements over longer distances, and seasonal variations correlated with temperature and vector abundance. 3) Control efforts included an emergency vaccination program using live attenuated vaccine beginning in July 2016. Over 500,000 vaccine doses were administered. Modeling estimated vaccine effectiveness was 76.5-62.5% at reducing

LSD symposium - E. Tuppurainen - Update on global distribution of lumpy skin ...

EuFMD

LSD symposium - J. Chan - Lumpy skin disease in Hong Kong

EuFMD

Dr. Jason Chan presented on the outbreak of Lumpy Skin Disease (LSD) in feral cattle populations in Hong Kong from 2020-2021. The key points were: 1) The initial outbreak was reported in October 2020 across multiple country parks. Disease investigation found that 72% of cattle in one herd showed skin lesions and 84% were seropositive. 2) By March 2021, no new clinical cases were reported. Surveillance since found 14 juveniles seronegative, suggesting LSD may have disappeared due to lack of susceptible newborn cattle. 3) Continued clinical and serological surveillance is important since Hong Kong has a small teaching farm. No urgency exists currently to declare freedom

LSD symposium - N. Zainuddin - Indonesian experience on simultaneous LSD and ...

EuFMD

1) Lumpy skin disease was first reported in Indonesia in February 2022 in Riau Province, and has since spread to several other provinces, most recently to Central Java in August 2022. 2) As of February 2023, over 249,000 cattle have been vaccinated across 9 provinces as a control measure. Other control measures include movement restrictions, vector control, and educating farmers. 3) Key challenges to control efforts include the extensive animal farming system, illegal animal movement, limited number of vaccinators, and high workload from controlling both lumpy skin disease and foot-and-mouth disease. Recommended solutions include improving handling capacity, better border control, engaging other institutions to assist with vaccination

LSD symposium - R. Ainsworth - Lumpy skin disease (LSD) in Southeast Asia Mar...

EuFMD

Lumpy Skin Disease (LSD) is spreading through cattle movements in Southeast Asia. The document discusses how government policies around quarantine, compensation and corruption can accelerate the virus's spread by encouraging illicit cattle movements. It also notes that traditional smuggling routes go against the direction LSD has spread. The rapid transmission of LSD occurred during COVID border closures, and its direction of movement corresponds with prevailing winds rather than cattle trade routes. Government policies and wind patterns may be aiding the long-distance airborne spread of LSD across Southeast Asia.

LSD symposium - P. Malik - Lumpy skin disease experience from India

EuFMD

Lumpy Skin Disease (LSD) was first reported in India in 2019. It has since spread to 23 states and union territories, affecting over 3 million animals and causing over 185,000 deaths. The disease manifests as skin nodules and lesions on internal organs. Vaccination is a key control strategy, with over 87 million animals vaccinated to date using a goatpox vaccine. ICAR has also developed an indigenous LSD vaccine that is undergoing field trials and licensing. States are implementing control measures like quarantine, vaccination, vector control and public awareness campaigns to curb the spread and impact of LSD.

LSD symposium - G. Cattoli - Lessons from ten years of experience building me...

EuFMD

LSD symposium - H. Bergmann - Systemic review and expert ranking of potential...

EuFMD

LSD symposium - E. Klemen - Modes of transmission of lumpy skin disease

EuFMD

Indirect transmission, likely through blood-sucking flying insects, is the primary mode of transmission for lumpy skin disease virus. While direct contact can transmit the virus, studies have found no transmission between clinically infected and susceptible cattle housed together without vectors. Mathematical models also indicate indirect transmission alone can explain outbreak dynamics. The virus can spread over long distances, possibly aided by winds carrying infected vectors, though local spread is typically 10 km per week. Subclinical infections may transmit the virus but appear to play a minor role compared to clinical cases.

More from EuFMD (20)